Physical activity in patients with microvascular complications of diabetes
Authors:
Martin Matoulek
Authors‘ workplace:
III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Published in:
Vnitř Lék 2015; 61(4): 340-345
Category:
Reviews
Overview
Physical activity is often underestimated and little used in the treatment of diabetes. The fear of damage, especially in patients with diabetes complications is one of the reasons why it occurs. Physical activity plays an important role in prevention of the progression of peripheral neuropathy and its impact is primarily on the development of muscle strength and the ability to replace the function of nerve fibers damaged disabilities. Demonstrable effect on neuropathy is already recorded a few weeks of regular exercise, long-term programs then demonstrate the safety of occurrence of ulcers in compliance with basic foot care. Present autonomic neuropathy cannot predict response to cardiac respectively, heart rate and blood pressure. Due to other risks (silent ischemia, arrhythmia etc.), it is appropriate to stress test before a prescription of exercise programs. Monitoring of blood pressure, heart rate and blood glucose during the first hours of physical activity is necessary. In patients with autonomic neuropathy of the gastrointestinal tract may significantly affect the composition of the diet not only the ability of physical activity, but can also affect hypoglycaemia due to a slow carbohydrate absorption in these patients. Another risk in patients with autonomic neuropathy is orthostatic hypotension, which may potentiate antihypertensive drugs in „white coat“ hypertension. Prescription of patients with retinopathy depends on the form and degree of retinopathy. Only proliferative retinopathy can significantly reduce exercise prescription, and it is always necessary to consult with ophthalmologist. In patients with nephropathy is an important stage of renal insufficiency for prescription of physical activity. Prescription is then influenced by the degree of renal insufficiency in addition to the presence of other associated diseases (anemia, hypertension, osteopathy etc.). Physical activity is essential in patients on dialysis respectively. After renal transplantation as maintaining peripheral muscle and its functions not only improves the prognosis, but also improves the quality of life and self-sufficiency is maintained.
Keywords:
diabetes complications – dialysis – physical activity – nephropathy – neuropathy – retinopathy
Sources
1. Matoulek M, Svačina Š, Lajka J. Výskyt obezity a jejích komplikací v České republice. Vnitř Lék 2010; 56(10): 1019–1027.
2. Chalder M, Wiles NJ, Campbell J et al. Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ 2012; 344: e2758. Dostupné z DOI: <http://doi: 10.1136/bmj.e2758>.
3. Caselini CM, Vinik AI. Clinical manifestation and current treatment options for diabetic neuropathies. Endocr Pract 2007; 13(5): 550–566.
4. Balducci S, Iacobellis G, Parisi L et al. Exercise training can midify the natural history of diabetic peripheral neuropathy. J Diabetes Complications 2006; 20(4): 216–223.
5. Kludding PM, Pasnoor M, Singh R et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications 2012; 26(5): 424–429.
6. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293(2): 217–228.
7. Tuttle LJ, HastingsMK, Mueller MJ. A moderate-intensity weight-bearing exercise program for a person with type 2 diabetes and peripheral neuropathy. Phys Ther 2012; 92(1); 133–141.
8. Lemaster JW, Muller MJ, Reiber GE et al. Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: feet first randomized controlled trial. Phys Ther 2008; 88(11): 1385–1398.
9. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115(3): 387–397.
10. Witte D, Tesfaye S, Chaturvedi N et al. Eurodiab Prospective Complications Study Group: Risk Factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005; 48(1): 164–171.
11. Kahn JK, Zola B, Juni J et al. Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care 1986; 9(4): 389–394.
12. Cheng YJ, Lauer MS, Earnest CP et al. Heart rate recovery following maximal exercise intensity in diabetic autonomic neruopathy. Diabetes Care 2003; 26(7): 2052–2057.
13. Loimaala A, Huikuri HV, Koobi T et al. Exercise training amproves baroreflex sensitivity in type 2 diabetes. Diabetes 2003; 52(7): 1837–1842.
14. Colberg SR, Swain DP, Vinik AI. Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care 2003; 26(4): 986–990.
15. Figuoeroa A, Basford JR, Low PA. Preventing and treating orthostatic hypotension: as easy as A, B, C. Cleve Clin J Med 2010; 77(5): 298–306.
16. Parkman HP, Fass R, Foxx-Orenstein AE. Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (NY) 2010; 6(6): 1–16.
17. Meyer C, Grossman R, MItrakou A et al. Effects of autonomic neuropathy on counterregulation an awarness of hypoglycemia in type 1 diabetic patients. Diabetes Care 1998; 21(11): 1960–1966.
18. Juutilainen A, Lehto S, Ronnemaa T et al. Retinopathy predicts cardiovasular mortality in type 2 diabetic men and women. Diabetes Care 2007; 30(2): 292–297.
19. Coccheri S. Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs 2007; 67(7): 917–1026.
20. Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther 2009; 31(11): 2608–2617.
21. Koh KH, Dayanath B, Doery JC et al. Effect of exercise on albuminuria in people with diabetes. Nephrology (Carlton) 2011; 16(8): 704–711.
22. Colberg SR, Sigal RJ, Fernhall B et al. The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 2010; 33(12): 2692–2696.
23. Johansen KL. Exercise and chronic kidney disease: current recommendations. Sports Med 2005; 35(6): 485–499.
24. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hypergylcaemia in type 2 diabetes : a patient-centered approach. Position statement of the American Diabetes Association (ADA) and European association for the Study od Diabetes (EASD). Diabetologia 2012; 55(6): 1577–1596.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2015 Issue 4
Most read in this issue
- Myokines – muscle tissue hormones
- The treatment of diabetes in patients with liver and renal impairment
- Treatment of GLP1 receptor agonists and body mass control
- Treatment of hypertension in diabetes mellitus